Lind Global Fund II LP 13D and 13G filings for Bone Biologics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:19 pm Unchanged | 2024-09-30 | 13G | Bone Biologics Corporation BBLG | Lind Global Fund II LP | 5,697 1.900% | 0 (Unchanged) | Filing |
| 2024-02-13 8:03 pm Purchase | 2023-12-31 | 13G | Bone Biologics Corporation BBLG | Lind Global Fund II LP | 5,697 6.000% | 5,697 (New Position) | Filing |